BDNF and osteosarcoma: Neurotrophin signaling reprograms the osteosarcoma microenvironment through coordinated actions on myeloid trafficking and polarization, antigen-presenting cell function, endothelial activation, and neuron–immune circuits that collectively degrade antitumor effector quality.